GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (MEX:0QBO) » Definitions » Institutional Ownership

Coloplast AS (MEX:0QBO) Institutional Ownership : 27.95% (As of Sep. 23, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Coloplast AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Coloplast AS's institutional ownership is 27.95%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Coloplast AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Coloplast AS's Float Percentage Of Total Shares Outstanding is 0.00%.


Coloplast AS Institutional Ownership Historical Data

The historical data trend for Coloplast AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Institutional Ownership Chart

Coloplast AS Historical Data

The historical data trend for Coloplast AS can be seen below:

2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31
Institutional Ownership 26.30 26.93 26.96 27.27 27.68 27.80 27.49 28.15 27.93 27.95

Coloplast AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines